Correlation Between Mink Therapeutics and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on Mink Therapeutics and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Mersana Therapeutics.
Diversification Opportunities for Mink Therapeutics and Mersana Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mink and Mersana is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Mersana Therapeutics
Given the investment horizon of 90 days Mink Therapeutics is expected to generate 1.15 times more return on investment than Mersana Therapeutics. However, Mink Therapeutics is 1.15 times more volatile than Mersana Therapeutics. It trades about 0.34 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about -0.46 per unit of risk. If you would invest 53.00 in Mink Therapeutics on October 25, 2024 and sell it today you would earn a total of 48.00 from holding Mink Therapeutics or generate 90.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 94.74% |
| Values | Daily Returns |
Mink Therapeutics vs. Mersana Therapeutics
Performance |
| Timeline |
| Mink Therapeutics |
| Mersana Therapeutics |
Mink Therapeutics and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mink Therapeutics and Mersana Therapeutics
The main advantage of trading using opposite Mink Therapeutics and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Mink Therapeutics vs. Terns Pharmaceuticals | Mink Therapeutics vs. X4 Pharmaceuticals | Mink Therapeutics vs. Day One Biopharmaceuticals | Mink Therapeutics vs. Hookipa Pharma |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world |